With the advent of new diseases and infections, antibodies are becoming a powerful tool in fighting diverse clinical settings: oncology, chronic inflammatory diseases, transplantation, infectious diseases and cardiovascular medicine.
Antibody drug discovery involves more cutting-edge techniques for the research and development. It is slightly more complex than a typical drug development, primarily due to methodology like target assessment & validation, screening preparation, hit generation, screening & lead selection, lead optimization & characterization, candidate selection and further scale up in bioreactor.
Eppendorf portfolio uses the instruments which not only support specific aim but also support entire workflow, thus working as a complete bundled solution for the antibody production. Use of these packages from Eppendorf ensures reproducibility, lower lead times and complete hassle-free joy of ownership.
This webinar covers various aspects of antibody research and aims at reducing total time for the discovery.
Date & Time: Webinar took place on Thursday, July 15, 2021
- Dr. Abhishek Mule, Bioprocess Application Specialist, Eppendorf Asia Pacific Africa
- Ms. Lu Foong Teng, Technical Product Specialist, Eppendorf Asia Pacific